Viewing StudyNCT00240383



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00240383
Status: COMPLETED
Last Update Posted: 2010-09-14
First Post: 2005-10-17

Brief Title: Dose Ranging Study With LT Monotherapy PPAR
Sponsor:
Organization: Bristol-Myers Squibb

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 1260
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: